Butterfly Network, Inc. (BFLY)
NYSE
Closed
Aug 28, 2026
Day's Range
8.4052 wk Range
1.47Overview - BFLY - Butterfly Network, Inc.
Key Statistics
Valuation
Enterprise Value
2.21B
P/E (Trailing)
‪-27.19‬
P/E (Forward)
‪-140.50‬
PEG Ratio
‪1.63‬
Price / Sales (TTM)
‪20.01‬
Price / Book
‪11.77‬
EV / EBITDA
‪-47.34‬
Profitability
Gross Margin
‪71.40%‬
Profit Margin
‪-66.74%‬
Operating Margin
‪-30.89%‬
Return on Assets
‪-10.46%‬
Return on Equity
‪-35.45%‬
Ownership
Shares Outstanding
264.42M
Float
220.20M
Short % of Shares Outstanding
‪15.04%‬
Held by Insiders
‪10.18%‬
Held by Institutions
‪61.44%‬
Price stats
Beta
‪2.08‬
50-Day Avg
‪8.06‬
200-Day Avg
‪4.99‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
5 analysts
Average price target
‪$ 9.31‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BFLY - Butterfly Network, Inc.
Peers - BFLY - Butterfly Network, Inc.
Peer Comparison
Compared with companies in Medical Devices listed on NYSE.
Profile Summary - BFLY - Butterfly Network, Inc.
About
Butterfly Network Inc. is a digital health company specializing in portable, semiconductor-based ultrasound technology. It develops and commercializes whole-body handheld ultrasound probes, including the Butterfly iQ+, iQ3, iQ+ Bladder for specialized bladder scanning, and iQ+ Vet for veterinary applications, all…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
